US EditionQuidelOrtho Nabs LEX in $100M M&A
Summary by San Diego Business Journal
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
QuidelOrtho Nabs LEX in $100M M&A
SAN DIEGO – Infectious disease diagnostic company QuidelOrtho (Nasdaq: QDEL) is refocusing its business strategy for molecular diagnostics following a new $100 million acquisition and the discontinuation of its Savanna PCR testing platform. Brian J. BlaserCEOQuidelOrtho QuidelOrtho announced earlier this month that it intends to acquire full ownership of molecular diagnostics company LEX Diagnostics following […]
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
